Depressive symptoms decline among persons on HIV protease inhibitors

Journal of Acquired Immune Deficiency Syndromes

Volumn 23, Issue 4, 2000, Pages 295-301

  Low Beer, Sophie ^a   Chan, Keith ^a   Yip, Benita ^a   Wood, Evan ^a   Montaner, Julio S G ^a,b   O'Shaughnessy, Michael V ^a,b   Hogg, Robert S ^a,b,c  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Brit Columbia Ctr Excell HIV/AIDS   (Canada)

Author keywords

AIDS; Antiretroviral therapy; CES D; Depression; HIV; Protease inhibitor

Indexed keywords

DIDANOSINE; INDINAVIR; LAMIVUDINE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AFFECT; ARTICLE; DEPRESSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RELATION; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PRIORITY JOURNAL;

EID: 0034177728     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200004010-00003     Document Type: Article

References (43)

1. Siegel JM, Angulo FJ, Detels R, Wesch J, Mullen A. AIDS diagnosis and depression in the Multicenter AIDS Cohort Study: the ameliorating impact of pet ownership. AIDS Care 1999;11:157-70
2. Hoover DR, Saah AJ, Bacellar H, et al. Signs and symptoms of "asymptomatic" HIV-1 infection in homosexual men. Multicenter AIDS Cohort Study [see comments]. J Acquir Immune Defic Syndr 1993;6:66-71.
3. Atkinson JH, Grant I, Kennedy CJ, Richman DD, Spector SA, McCutchan JA. Prevalence of psychiatric disorders among men infected with human immunodeficiency virus: a controlled study. Arch Gen Psychiatry 1988;45:859-64.
4. Rabkin JG, Ferrando SJ, Jacobsberg LB, Fishman B. Prevalence of axis 1 disorders in an AIDS cohort: a cross-sectional, controlled study. Compr Psychiatry 1997;38:146-54.
5. Lyketsos CG, Hanson AL, Fishman M, McHugh PR, Treisman GJ. Screening for psychiatric disorders in an HIV medical clinic: the importance of a psychiatric presence. Int J Psychiatry Med 1994; 24:103-13.
6. Lyketsos CG, Hoover DR, Guccione M, et al. Changes in depressive symptoms as AIDS develops. The Multicenter AIDS Cohort Study. Am J Psychiatry 1996;153:1430-7.
7. Wells KB, Stewart A, Hays RD, et al. The functioning and wellbeing of depressed patients. JAMA 1989,262:914-19.
8. Black DW, Warrack G, Winokur G. The Iowa Record-Linkage Study, III: excess mortality among patients with 'functional' disorders. Arch Gen Psychiatry 1985;42:82-8.
9. Black DW, Warrack G, Winokur G. The Iowa Record-Linkage Study, I: suicides and accidental deaths among psychiatric patients. Arch Gen Psychiatry 1985;42:71-5.
10. Martin RC, Cloninger R, Guze S, Clayton PJ. Mortality in a follow-up of 500 psychiatric outpatients, II: cause-specific mortality. Arch Gen Psychiatry 1985;42:58-66.
11. Martin RC, Cloninger R, Guze S, Clayton PJ. Mortality in a follow-up of 500 psychiatric outpatients, I: total mortality. Arch Gen Psychiatry 1985;42:47-54.
12. Marzuk PM, Tierney H, Tardiff K, et al. Increased risk of suicide in persons with AIDS. JAMA 1988;259:1333-7.
13. O'Dowd MA, McKegney FP. AIDS patients compared with others as seen in psychiatric consultation. Gen Hasp Psychiatry 1990;12: 50-5.
14. Holland JC, Tross S. The psychosocial and neuropsychiatrie sequelae of acquired immunodeficiency syndrome and related disorders. Ann Intern Med 1985:103:760-4.
15. Lyketsos CG, Hoover DR, Guccione M, et al. Depressive symptoms as predictors of medical outcomes in HIV infection. Multicenter AIDS Cohort Study [see comments]. JAMA 1993;270: 2563-7.
16. Burack JH, Barrett DC, Stall RD, Chesney MA, Ekstrand ML, Coates TJ. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men [see comments]. JAMA 1993;270:2568-73.
17. Hoover DR, Saah A, Bacellar H, Detes R, Phair J. The progression of untreated HIV-1 infection prior to AIDS. Am J Public Health 1992;82:1538-41.
18. Rosenberger PH, Bomstein RA, Nasrallah HA. Psychopathology in HIV infection: lifetime and current assessment. Compr Psychiatry 1993;34:150-8.
19. Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV in 1997: updated recommendations of an international panel. JAMA 1997;277:1962-9.
20. Montaner JS, Hogg RS, O'Shaughnessy MV. Emerging international consensus for use of antiretroviral therapy [see comments]. Lancet 1997:349:1042.
21. Hogg RS, O'Shaughnessy MV, Gataric N, et al. Decline in deaths from AIDS due to new antiretrovirals [letter]. Lancet 1997;349: 1294.
22. Hogg RS, Heath KV, Yip B, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy [see comments]. JAMA 1998:279:450-4.
23. Gulick RM. Current antiretroviral therapy: an overview. Qual Life Res 1997;6:471-4.
24. Reiter GS. Human immunodeficiency virus (HIV) in America, 1981 to 1997: epidemiologic and therapeutic considerations. Semin Ultrasound CT MRI 1998;19:122-7.
25. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998;12:F51-8.
26. BC Centre for Excellence in HIV/AIDS. Therapeutic guidelines for the treatment of HIV/AIDS and related conditions. British Columbia: St. Paul's Hospital, 1999.
27. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1: 385-401.
28. Devins GM, Orme C, C.G. C, Binik VM, McCloskey B, Briggs G. Measuring depressive symptoms in illness populations: psychometric properties of the Center for Epidemiologic Studies Depression (CES-D) Scale. Psychol Health 1988;2:139-56.
29. Weissman MM, Scholomskas O, Pottenger M, et al. Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol 1977:106:203-14.
30. Lyketsos CG, Hoover DR, Guccione M, et al. Depressive symptoms over the course of HIV infection before AIDS. Soc Psychiatry Psychiatr Epidemiol 1996;31:212-9.
31. Lenderking WR, Gelber RD, Cotton DJ, et al. Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group [see comments]. N Engl J Med 1994:330:738-43.
32. Wu AW, Rubin HR, Mathews WC, et al. Functional status and well-being in a placebo-controlled trial of zidovudine in early symptomatic HIV infection. J Acquir Immune Defic Syndr 1993; 6:452-8.
33. Lubeck DP, Fries JF. Changes in quality of life among persons with HIV infection. Qual Life Res 1992:1:359-66.
34. Montaner JS, Hogg R, Raboud J, Harrigan R, O'Shaughnessy M. Antiretroviral treatment in 1998. Lancet 1998,352:1919-22.
35. Ostrow DG, Monjan A, Joseph J, et al. HIV-related symptoms and psychological functioning in a cohort of homosexual men. Am J Psychiatry 1989;146:737-42.
36. Drebing CE, Van Gorp WG, Hinkin C, et al. Confounding factors in the measurement of depression in HIV. J Pers Assess 1994;62: 68-83.
37. Katz MH, Douglas JM Jr, Bolan GA, et al. Depression and use of mental health services among HIV-infected men. AIDS Care 1996; 8:433-42.
38. Revicki DA, Brown RE, Henry DH, McNeill MV, Rios A, Watson T. Recombinant human erythropoietin and health-related quality of life of AIDS patients with anemia. J Acquir Immune Defic Syndr 1994;7:474-84.
39. Revicki DA, Moyle G, Stellbrink HJ, Barker C. Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. AIDS 1999;13:851-8.
40. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-IIIR psychiatric disorders in the United States. Arch Gen Psychiatry 1994;51:8-19.
41. Lyketsos CG, Hutton H, Fishman M, Schwartz J, Treisman GJ. Psychiatric morbidity on entry to an HIV primary care clinic. AIDS 1996:10:1033-9.
42. Cunningham WE, Bozzette SA, Hays RD, Kanouse DE, Shapiro MF. Comparison of health-related quality of life in clinical trial and nonclinical trial human immunodeficiency virus-infected cohorts. Med Care 1995:33(4 Suppl):AS15-25.
43. Mulrow CD, Williams JW, Geretty MB, et al. Case-finding instruments for depression in primary care settings. Ann Intern Med 1995;122:913-21.